Texas plans to spend $50 million on research examining the effects of a psychedelic drug called Ibogaine on behavioral health ...

Ibogaine is illegal in the U.S., but growing evidence shows its promise treating the effects of traumatic brain injury and ...

Texas judges produced “more than half” of all universal injunctions issued during the terms of former Presidents Barack Obama ...

A federal judge in Texas has upheld the FDA’s decision to remove GLP-1 drugs, including Novo Nordisk’s Ozempic and Wegovy, from its drug shortage list, rejecting a bid by compounding pharmacies to ...

On June 18, 2025, the U.S. Food and Drug Administration (“FDA”) announced an immediate review of new clinical trials that ...

House Bill 3057 removes barriers for rural cancer centers to offer CAR T therapy, reducing travel strain for patients and ...

Industry experts note some naturally derived ingredients would also require disclosures, leading to consumer confusion.